A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33 + Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33 + Acute Myeloid Leukemia

Published:2016-04 Issue:4 Volume:22 Page:698-704
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Zahler Stacey,Bhatia Monica,Ricci Angela,Roy Sumith^ORCID,Morris Erin,Harrison Lauren,van de Ven Carmella,Fabricatore Sandra,Wolownik Karen,Cooney-Qualter Erin,Baxter-Lowe Lee Ann,Luisi Paul,Militano Olga,Kletzel Morris^ORCID,Cairo Mitchell S.

Funder

Pediatric Cancer Research Foundation

Paul Luisi Jr. Foundation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference53 articles.

1. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group;Aplenc;Blood,2006

2. Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep;Woods;Pediatr Blood Cancer,2006

3. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia;Meshinchi;Oncologist,2007

4. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission;Woods;Blood,2001

5. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry;Socie;N Engl J Med,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience;Frontiers in Immunology;2023-12-22

2. A Prognostic Model of Seven Immune Genes to Predict Overall Survival in Childhood Acute Myeloid Leukemia;BioMed Research International;2022-12-05

3. Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas;Cancers;2022-10-14

4. Diagnostic challenges in acute monoblastic/monocytic leukemia in children;Frontiers in Pediatrics;2022-09-28

5. Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial;Bone Marrow Transplantation;2022-08-26